These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 19193429)
1. Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients. Klasa-Mazurkiewicz D; Narkiewicz J; Milczek T; Lipińska B; Emerich J Gynecol Oncol; 2009 Apr; 113(1):91-8. PubMed ID: 19193429 [TBL] [Abstract][Full Text] [Related]
2. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma. Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598 [TBL] [Abstract][Full Text] [Related]
3. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study. ; Secord AA; Lee PS; Darcy KM; Havrilesky LJ; Grace LA; Marks JR; Berchuck A Gynecol Oncol; 2006 Jun; 101(3):390-7. PubMed ID: 16551475 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients. Klasa-Mazurkiewicz D; Jarząb M; Milczek T; Lipińska B; Emerich J Pol J Pathol; 2011; 62(1):31-40. PubMed ID: 21574104 [TBL] [Abstract][Full Text] [Related]
5. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer. Bauerschlag DO; Habermann M; Weimer J; Meinhold-Heerlein I; Hilpert F; Weigel M; Bauer M; Mundhenke C; Jonat W; Maass N; Schem C Anticancer Res; 2010 Jul; 30(7):2739-44. PubMed ID: 20683007 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients. Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446 [TBL] [Abstract][Full Text] [Related]
8. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717 [TBL] [Abstract][Full Text] [Related]
9. [Expression of maspin and its relation to tumor vascularization in epithelian ovarian cancer]. Ma Y; Peng ZL Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):223-7. PubMed ID: 19462894 [TBL] [Abstract][Full Text] [Related]
13. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671 [TBL] [Abstract][Full Text] [Related]
14. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma]. He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404 [TBL] [Abstract][Full Text] [Related]
15. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma. Sopel M; Surowiak P; Berdowska I Folia Morphol (Warsz); 2010 Nov; 69(4):204-12. PubMed ID: 21120806 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875 [TBL] [Abstract][Full Text] [Related]
18. EphA2 expression is associated with aggressive features in ovarian carcinoma. Thaker PH; Deavers M; Celestino J; Thornton A; Fletcher MS; Landen CN; Kinch MS; Kiener PA; Sood AK Clin Cancer Res; 2004 Aug; 10(15):5145-50. PubMed ID: 15297418 [TBL] [Abstract][Full Text] [Related]
19. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis. Castellvi J; Garcia A; de la Torre J; Hernandez J; Gil A; Xercavins J; Ramón y Cajal S Hum Pathol; 2006 Jul; 37(7):883-9. PubMed ID: 16784989 [TBL] [Abstract][Full Text] [Related]
20. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study. Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]